These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26835991)

  • 81. Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL.
    Leeman JR; Weniger MA; Barth TF; Gilmore TD
    Oncogene; 2008 Dec; 27(53):6770-81. PubMed ID: 18695674
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Molecular profiling of estrogen receptor α and progesterone receptor transcript variants in endometrial cancer.
    Skrzypczak M; Merx I; Schüler-Toprak S; Weber F; Inwald EC; Ortmann O; Treeck O
    Steroids; 2015 Dec; 104():122-8. PubMed ID: 26428028
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A distal estrogen responsive element upstream the cap site of human transthyretin gene is an enhancer-like element upon ERα and/or ERβ transactivation.
    Martinho A; Santos CR; Gonçalves I
    Gene; 2013 Sep; 527(2):469-76. PubMed ID: 23860318
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Differential expression of estrogen receptor-beta (ER beta) in human pituitary tumors: functional interactions with ER alpha and a tumor-specific splice variant.
    Chaidarun SS; Swearingen B; Alexander JM
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3308-15. PubMed ID: 9745446
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Capacity of type I and II ligands to confer to estrogen receptor alpha an appropriate conformation for the recruitment of coactivators containing a LxxLL motif-Relationship with the regulation of receptor level and ERE-dependent transcription in MCF-7 cells.
    Bourgoin-Voillard S; Gallo D; Laïos I; Cleeren A; Bali LE; Jacquot Y; Nonclercq D; Laurent G; Tabet JC; Leclercq G
    Biochem Pharmacol; 2010 Mar; 79(5):746-57. PubMed ID: 19879249
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Transactivation Function-1-Mediated Partial Agonist Activity of Selective Estrogen Receptor Modulator Requires Homo-Dimerization of the Estrogen Receptor α Ligand Binding Domain.
    Arao Y; Korach KS
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366023
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Function of N-terminal transactivation domain of the estrogen receptor requires a potential alpha-helical structure and is negatively regulated by the A domain.
    Métivier R; Petit FG; Valotaire Y; Pakdel F
    Mol Endocrinol; 2000 Nov; 14(11):1849-71. PubMed ID: 11075817
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta.
    van de Stolpe A; Slycke AJ; Reinders MO; Zomer AW; Goodenough S; Behl C; Seasholtz AF; van der Saag PT
    Mol Endocrinol; 2004 Dec; 18(12):2908-23. PubMed ID: 15345745
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Dominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets.
    Belaguli NS; Zhou W; Trinh TH; Majesky MW; Schwartz RJ
    Mol Cell Biol; 1999 Jul; 19(7):4582-91. PubMed ID: 10373507
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Binding of the ERα and ARNT1 AF2 domains to exon 21 of the SRC1 isoform SRC1e is essential for estrogen- and dioxin-related transcription.
    Endler A; Chen L; Zhang J; Xu GT; Shibasaki F
    J Cell Sci; 2012 Apr; 125(Pt 8):2004-16. PubMed ID: 22328528
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A dynamic structural model for estrogen receptor-alpha activation by ligands, emphasizing the role of interactions between distant A and E domains.
    Métivier R; Stark A; Flouriot G; Hübner MR; Brand H; Penot G; Manu D; Denger S; Reid G; Kos M; Russell RB; Kah O; Pakdel F; Gannon F
    Mol Cell; 2002 Nov; 10(5):1019-32. PubMed ID: 12453411
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Estrogen and Estrogen Receptor-α-Mediated Transrepression of Bile Salt Export Pump.
    Chen Y; Vasilenko A; Song X; Valanejad L; Verma R; You S; Yan B; Shiffka S; Hargreaves L; Nadolny C; Deng R
    Mol Endocrinol; 2015 Apr; 29(4):613-26. PubMed ID: 25675114
    [TBL] [Abstract][Full Text] [Related]  

  • 93. p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains.
    Kobayashi Y; Kitamoto T; Masuhiro Y; Watanabe M; Kase T; Metzger D; Yanagisawa J; Kato S
    J Biol Chem; 2000 May; 275(21):15645-51. PubMed ID: 10747867
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Calmodulin, a regulatory partner of the estrogen receptor alpha in breast cancer cells.
    Gallo D; Jacquot Y; Laurent G; Leclercq G
    Mol Cell Endocrinol; 2008 Sep; 291(1-2):20-6. PubMed ID: 18524472
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The pure estrogen receptor antagonist ICI 182,780 promotes a novel interaction of estrogen receptor-alpha with the 3',5'-cyclic adenosine monophosphate response element-binding protein-binding protein/p300 coactivators.
    Jaber BM; Gao T; Huang L; Karmakar S; Smith CL
    Mol Endocrinol; 2006 Nov; 20(11):2695-710. PubMed ID: 16840538
    [TBL] [Abstract][Full Text] [Related]  

  • 96. In silico design of peptidic inhibitors targeting estrogen receptor alpha dimer interface.
    Chakraborty S; Cole S; Rader N; King C; Rajnarayanan R; Biswas PK
    Mol Divers; 2012 Aug; 16(3):441-51. PubMed ID: 22752657
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Microwave-assisted synthesis, characterization and cytotoxic studies of novel estrogen receptor α ligands towards human breast cancer cells.
    Bharathkumar H; Mohan CD; Ananda H; Fuchs JE; Li F; Rangappa S; Surender M; Bulusu KC; Girish KS; Sethi G; Bender A; Basappa ; Rangappa KS
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1804-1807. PubMed ID: 25797502
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Expression and function of variants of human catecholamine transporters lacking the fifth transmembrane region encoded by exon 6.
    Sogawa C; Mitsuhata C; Kumagai-Morioka K; Sogawa N; Ohyama K; Morita K; Kozai K; Dohi T; Kitayama S
    PLoS One; 2010 Aug; 5(8):e11945. PubMed ID: 20700532
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Identification and expression analysis of a novel transcript of the human PRMT2 gene resulted from alternative polyadenylation in breast cancer.
    Zhong J; Cao RX; Hong T; Yang J; Zu XY; Xiao XH; Liu JH; Wen GB
    Gene; 2011 Nov; 487(1):1-9. PubMed ID: 21820040
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Transcriptional interaction of an estrogen receptor splice variant and ErbB4 suggests convergence in gene susceptibility pathways in schizophrenia.
    Wong J; Weickert CS
    J Biol Chem; 2009 Jul; 284(28):18824-32. PubMed ID: 19439407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.